Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma levels of miR-137 and miR-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depression
Na Li, Xudong Pan, Jingli Zhang, et al.
Neurological Sciences (2017) Vol. 38, Iss. 5, pp. 761-767
Closed Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Chen Li, Yu‐Qing Ni, Hui Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 273
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
Merel M.J. van den Berg, Julian Krauskopf, Johannes G. Ramaekers, et al.
Progress in Neurobiology (2019) Vol. 185, pp. 101732-101732
Open Access | Times Cited: 208
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 107
Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
Anna Elisa Roser, Lucas Caldi Gomes, Jonas Schünemann, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 120
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Pharmacological Research (2019) Vol. 150, pp. 104515-104515
Closed Access | Times Cited: 118
The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases
Xiaoyu Wang, Yunxiang Zhou, Qiannan Gao, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-17
Open Access | Times Cited: 115
Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease
Jessica Schulz, Petros Takousis, Inken Wohlers, et al.
Annals of Neurology (2019) Vol. 85, Iss. 6, pp. 835-851
Open Access | Times Cited: 99
Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson’s disease
Yan Jiang, Jing Liu, Luzhu Chen, et al.
Brain Research (2019) Vol. 1722, pp. 146331-146331
Closed Access | Times Cited: 95
The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury
Xiaolu Liu, Zhitao Feng, Lipeng Du, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 120-120
Open Access | Times Cited: 81
MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review
Yong Hui Nies, Nor Haliza Mohamad Najib, Wei Ling Lim, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 77
The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
Ming‐Che Kuo, Sam Chi-Hao Liu, Ya-Fang Hsu, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 72
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson’s disease
Marta Esteves, Ricardo C. de Abreu, Hugo Fernandes, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3176-3192
Open Access | Times Cited: 64
An update on the role of miR-124 in the pathogenesis of human disorders
Soudeh Ghafouri‐Fard, Hamed Shoorei, Zahra Bahroudi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111198-111198
Open Access | Times Cited: 63
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 59
MicroRNAs’ role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration
Marwa M. Mahmoud, Eman F. Sanad, Nadia Μ. Hamdy
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 28, pp. 36984-37000
Open Access | Times Cited: 57
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 48
Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease
Xin Gong, Mengyi Huang, Lei Chen
eNeuro (2022) Vol. 9, Iss. 1, pp. ENEURO.0393-21.2021
Open Access | Times Cited: 45
Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111800-111800
Closed Access | Times Cited: 25
Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease
Xiong Zhang, Rui Yang, Beilei Hu, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 71
Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases
Albin John, Aaron Kubosumi, P. Hemachandra Reddy
Cells (2020) Vol. 9, Iss. 6, pp. 1345-1345
Open Access | Times Cited: 70
The Neuroprotective Role of MiR‐124‐3p in a 6‐Hydroxydopamine‐Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5
Ruifang Dong, Bing Zhang, Liwen Tai, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 1, pp. 269-277
Closed Access | Times Cited: 69
Down regulation of miR‐218, miR‐124, and miR‐144 relates to Parkinson's disease via activating NF‐κB signaling
Ruixian Xing, Longguang Li, Xuewen Liu, et al.
The Kaohsiung Journal of Medical Sciences (2020) Vol. 36, Iss. 10, pp. 786-792
Open Access | Times Cited: 53
Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
Stylianos Ravanidis, Anastasia Bougea, Nikolaos Papagiannakis, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 9, pp. 1594-1607
Open Access | Times Cited: 53
MicroRNAs Play a Role in Parkinson’s Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential
Silu Li, Guorong Bi, Shunchang Han, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 33
Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics
Sai Nikhil Uppala, Kamatham Pushpa Tryphena, Padmashri Naren, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111826-111826
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top